Group 1 - The Pennant Group, Inc. reported quarterly earnings of 0.24pershare,missingtheZacksConsensusEstimateof0.25 per share, but showing an increase from 0.22pershareayearago,resultinginanearningssurpriseof−4188.89 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 1.12%, and compared to year-ago revenues of 145.95million[2]−Thestockhasunderperformedthemarket,losingabout3.90.24 on revenues of 196.7million,andforthecurrentfiscalyear,itis1.08 on revenues of $809.14 million [7] - The Medical - Outpatient and Home Healthcare industry is currently in the top 31% of Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - The estimate revisions trend for The Pennant Group is mixed, resulting in a Zacks Rank 3 (Hold), suggesting the shares are expected to perform in line with the market in the near future [6]